Mechanism and consequence of chitosan-mediated reversible epithelial tight junction opening

Biomaterials

Volumn 32, Issue 26, 2011, Pages 6164-6173

  Yeh, Tzyy Harn ^a   Hsu, Li Wen ^a   Tseng, Michael T ^b   Lee, Pei Ling ^a   Sonjae, Kiran ^a   Ho, Yi Cheng ^c   Sung, Hsing Wen ^a  

^a NATIONAL TSING HUA UNIVERSITY   (Taiwan)

^b University of Louisville School of Medicine   (United States)

^c VANUNG UNIVERSITY   (Taiwan)

Author keywords

Chitosan; Claudin 4; Epithelial cell; Paracellular transport; Tight junction

Indexed keywords

CACO-2 CELLS; CLAUDIN-4; CONTRIBUTING FACTOR; EPITHELIAL CELLS; FURTHER DEVELOPMENT; GENE TRANSCRIPTIONS; HYDROPHILIC MACROMOLECULES; MOLECULAR LEVELS; PARACELLULAR PERMEABILITY; PARACELLULAR TRANSPORT; PERMEATION ENHANCERS; PROTEIN EXPRESSION LEVELS; PROTEIN SYNTHESIS; SMALL INTESTINE; TIGHT JUNCTIONS; TRANSMEMBRANES;

BIOSYNTHESIS; CELLS; DRUG DELIVERY; DRUG INTERACTIONS; GENES; MONOLAYERS; POWER QUALITY; PROTEINS; TRANSCRIPTION; TRANSMISSION ELECTRON MICROSCOPY;

CHITOSAN;

CHITOSAN; CLAUDIN 4;

ARTICLE; CELL INTERACTION; CELL MEMBRANE PERMEABILITY; CELL STRAIN CACO 2; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ELECTRIC RESISTANCE; EPITHELIUM CELL; GENE DISRUPTION; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; LYSOSOME; MONOLAYER CULTURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; TIGHT JUNCTION; TRANSEPITHELIAL ELECTRICAL RESISTANCE; TRANSMISSION ELECTRON MICROSCOPY;

BLOTTING, WESTERN; CACO-2 CELLS; CHITOSAN; CLAUDINS; EPITHELIAL CELLS; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY, ELECTRON, TRANSMISSION; POLYMERASE CHAIN REACTION; TIGHT JUNCTIONS;

EID: 79959876473     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2011.03.056     Document Type: Article

References (41)

1. Sonaje K., Lin K.J., Wang J.J., Mi F.L., Chen C.T., Juang J.H., et al. Self-assembled pH-sensitive nanoparticles: a platform for oral delivery of protein drugs. Adv Funct Mater 2010, 20:3695-3700.
2. Kotzé A.F., Luessen H.L., de Leeuw B.J., de Boer A.G., Verhoef J.C., Junginger H.E. Comparison of the effect of different chitosan salts and N-trimethyl chitosan chloride on the permeability of intestinal epithelial cells (Caco-2). J Control Release 1998, 51:35-46.
3. Ballard S.T., Hunter J.H., Taylor A.E. Regulation of tight-junction permeability during nutrient absorption across the intestinal epithelium. Annu Rev Nutr 1995, 15:35-55.
4. Banan A., Zhang L.J., Shaikh M., Fields J.Z., Choudhary S., Forsyth C.B., et al. θ Isoform of protein kinase C alters barrier function in intestinal epithelium through modulation of distinct claudin isotypes: a novel mechanism for regulation of permeability. Pharmacol Exp Ther 2005, 313:962-982.
5. Stamatovic S.M., Keep R.F., Kunkel S.L., Andjelkovic A.V. Potential role of MCP-1 in endothelial cell tight junction 'opening': signaling via Rho and Rho kinase. J Cell Sci 2003, 116:4615-4628.
6. Tsukita S., Furuse M., Itoh M. Multifunctional strands in tight junctions. Nat Rev Mol Cell Biol 2001, 2:285-293.
7. Sheth P., Samak G., Shull J.A., Seth A., Rao R. Protein phosphatase 2A plays a role in hydrogen peroxide-induced disruption of tight junctions in Caco-2 cell monolayers. Biochem J 2009, 421:59-70.
8. Tsukita S., Furuse M. Pores in the wall: claudins constitute tight junction strands containing aqueous pores. J Cell Biol 2000, 149:13-16.
9. Thanou M., Verhoef J.C., Junginger H.E. Chitosan and its derivatives as intestinal absorption enhancers. Adv Drug Deliv Rev 2001, 50(Suppl. 1):S91-S101.
10. Thanou M., Verhoef J.C., Junginger H.E. Oral drug absorption enhancement by chitosan and its derivatives. Adv Drug Deliv Rev 2001, 52:117-126.
11. Sonaje K., Lin Y.H., Juang J.H., Wey S.P., Chen C.T., Sung H.W. In vivo evaluation of safety and efficacy of self-assembled nanoparticles for oral insulin delivery. Biomaterials 2009, 30:2329-2339.
12. Takeuchi H., Thongborisute J., Matsui Y., Sugihara H., Yamamoto H., Kawashima Y. Novel mucoadhesion tests for polymers and polymer-coated particles to design optimal mucoadhesive drug delivery systems. Adv Drug Deliv Rev 2005, 57:1583-1594.
13. Sonaje K., Chen Y.J., Chen H.L., Wey S.P., Juang J.H., Nguyen H.N., et al. Enteric-coated capsules filled with freeze-dried chitosan/poly(gamma-glutamic acid) nanoparticles for oral insulin delivery. Biomaterials 2010, 31:3384-3394.
14. Illum R. Chitosan and its use as a pharmacological excipient. Pharm Res 1998, 15:1326-1331.
15. Illum L., Watts P., Fisher A., Hinchcliffe M., Norbury H., Jabbal-Gill I., et al. Intranasal delivery of morphine. J Pharmacol Exp Ther 2002, 301:391-400.
16. Degim I., Acarturk F., Erdogan D., Lortlar N. Transdermal administration of bromocriptine. Biol Pharm Bull 2003, 26:501-505.
17. Bolgul Y., Hekimoglu S., Sahin-Erdemli I., Kas H. Evaluation of oxprenolol hydrochloride permeation through isolated human skin and pharmacodynamic effect in rats. STP Pharma Sci 1998, 8:197-201.
18. Peng S.F., Tseng M.T., Ho Y.C., Wei M.C., Liao Z.X., Sung H.W. Mechanisms of cellular uptake and intracellular trafficking with chitosan/DNA/poly(γ-glutamic acid) complexes as a gene delivery vector. Biomaterials 2011, 32:239-248.
19. Sonaje K., Lin K.J., Wey S.P., Lin C.K., Yeh T.H., Nguyen H.N., et al. Biodistribution, pharmacodynamics and pharmacokinetics of insulin analogues in a rat model: oral delivery using pH-responsive nanoparticles vs. subcutaneous injection. Biomaterials 2010, 31:6849-6858.
20. Chen M.C., Wong H.S., Lin K.J., Chen H.L., Wey S.P., Sonaje K., et al. The characteristics, biodistribution and bioavailability of a chitosan-based nanoparticulate system for the oral delivery of heparin. Biomaterials 2009, 30:6629-6637.
21. Liao Z.X., Ho Y.C., Chen H.L., Peng S.F., Hsiao C.W., Sung H.W. Enhancement of efficiencies of the cellular uptake and gene silencing of chitosan/siRNA complexes via the inclusion of a negatively charged poly(γ-glutamic acid). Biomaterials 2010, 31:8780-8788.
22. Dodane V., Amin Khan M., Merwin J. Effect of Caco-2 on epithelial permeability and structure. Int J Pharm 1999, 182:21-32.
23. Smith J., Dornish M., Wood E.J. Effect of chitosan on epithelial cell tight junctions. Pharm Res 2004, 21:43-49.
24. Smith J.M., Dornish M., Wood E.J. Involvement of protein kinase C in chitosan glutamate-mediated tight junction disruption. Biomaterials 2005, 26:3269-3276.
25. Nguyen H.N., Wey S.P., Juang J.H., Sonaje K., Ho Y.C., Chuang E.Y., et al. The glucose-lowering potential of exendin-4 orally delivered via a pH-sensitive nanoparticle vehicle and effects on subsequent insulin secretion in vivo. Biomaterials 2011, 32:2673-2682.
26. Rousset M. The human colon carcinoma cell lines HT-29 and Caco-2: two in vitro models for the study of intestinal differentiation. Biochimie 1986, 68:1035-1040.
27. Quaroni A. Crypt cell antigen expression in human colon tumor cell lines: analysis with a panel of monoclonal antibodies to CaCo-2 luminal membrane components. J Natl Cancer Inst 1986, 76:571-585.
28. Quaroni A., Weiser M.M., Lee S., Amodeo D. Expression of developmentally regulated crypt cell antigens in human and rat intestinal tumors. J Natl Cancer Inst 1986, 77:405-415.
29. Keely S., Rullay A., Wilson C., Carmichael A., Carrington S., Corfield A., et al. In vitro and ex vivo intestinal tissue models to measure mucoadhesion of poly (methacrylate) and N-trimethylated chitosan polymers. Pharm Res 2005, 22:38-49.
30. Dhaliwal S., Jain S., Singh H.P., Tiwary A.K. Mucoadhesive microspheres for gastroretentive delivery of acyclovir: in vitro and in vivo evaluation. AAPS J 2008, 10:322-330.
31. Qaqish R.B., Amiji M.M. Synthesis of a fluorescent chitosan derivative and its application for the study of chitosan-mucin interactions. Carbohydr Polym 1999, 38:99-107.
32. Lee P.W., Peng S.F., Su C.J., Mi F.L., Chen H.L., Wei M.C., et al. The use of biodegradable polymeric nanoparticles in combination with a low-pressure gene gun for transdermal DNA delivery. Biomaterials 2008, 29:742-751.
33. Prusty A.K., Sahu S.K. Biodegradable nanoparticles - a novel approach for oral administration of biological products. Int J Pharm Sci Nanotech 2009, 2:503-508.
34. Lin Y.H., Sonaje K., Lin K.M., Juang J.H., Mi F.L., Yang H.W., et al. Multi-ion-crosslinked nanoparticles with pH-responsive characteristics for oral delivery of protein drugs. J Control Release 2008, 132:141-149.
35. Matter K., Balda M. Signalling to and from tight junctions. Nat Rev Mol Cell Biol 2003, 4:225-237.
36. Hossain Z., Hirata T. Molecular mechanism of intestinal permeability: interaction at tight junctions. Mol Biosyst 2008, 4:1181-1185.
37. Heiskala M., Peterson P.A., Yang Y. The roles of claudin superfamily proteins in paracellular transport. Traffic 2001, 2:93-98.
38. Furuse M., Hata M., Furuse K., Yoshida Y., Haratake A., Sugitani Y., et al. Claudin-based tight junctions are crucial for the mammalian epidermal barrier: a lesson from claudin-1-deficient mice. J Cell Biol 2002, 156:1099-1111.
39. Baccino F.M., Tessitore L., Bonelli G. Control of protein degradation and growth phase in normal and neoplastic cells. Toxicol Pathol 1984, 12:281-287.
40. Sheff D.R., Kroschewski R., Mellman I. Actin dependence of polarized receptor recycling in Madin-Darby canine kidney cell endosomes. Mol Biol Cell 2002, 13:262-275.
41. Medigeshi G.R., Hirsch A.J., Brien J.D., Uhrlaub J.L., Mason P.W., Wiley C., et al. West nile virus capsid degradation of claudin proteins disrupts epithelial barrier function. J Virol 2009, 83:6125-6134.